is it safe to switch from tirzepatide to semaglutide vs. Semaglutide: What You Should Know tirzepatide to semaglutide switch is
Description
Prescribing Information for GLP-1s
This warning states that tirzepatide causes thyroid C-cell tumors at clinically relevant exposures in rodents, and that it is unknown whether tirzepatide causes thyroid C-cell tumors, including medullary thyroid carcinoma, in humans
The enzymatic activity of dipeptidyl peptidase IV (DPP-4) leads to GLP-1 degradation and inactivation
Most effects are mild to moderate and decrease as your body adapts
And most importantly, work with a provider you trust, like our experienced team at Refine Laser & Skin Care
